Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nux vomica extract is a botanical preparation derived from the seeds of the *Strychnos nux-vomica* tree, primarily containing the alkaloids strychnine and brucine. Historically utilized as a central nervous system stimulant and tonic, its primary mechanism of action involves the competitive antagonism of glycine receptors in the spinal cord and brainstem, which leads to increased neuronal excitability. In modern clinical research, it is often studied in the context of toxicology, safety, or as a stimulant in healthy volunteer populations to assess physiological effects and potential for misuse, particularly in anti-doping studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nux vomica extract.